MADRIGAL PHARMACEUTICALS, INC.

By person

17 insiders · 204 transactions

117×

Bill Sibold holds 117 times base salary in stock. $108.04M of shares against $918.53K in salary for 2025.

Salary from the company's own proxy. The shares are what Bill Sibold last reported holding, valued at $546.38, the price Common Stock was last bought or sold at on the open market here, on 11 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

FRIEDMAN PAUL A

Director

—

$26.66M (38) scheduled

−$26.66M

187,164

0.8101%

$102.26M

+0.4%

Taub Rebecca

Director

—

$21.68M (42) scheduled

−$21.68M

452,667

1.96%

$247.33M

−1.4%

Sibold William John

President and CEO

—

$10.48M (37) scheduled

−$10.48M

197,746

0.8559%

$108.04M

+253.8%

BATE KENNETH

Director

—

$8.03M (11) scheduled

−$8.03M

2,627

0.0114%

$1.44M

+37.4%

Levy Richard S

Director

—

$7.36M (26) scheduled

−$7.36M

22,469

0.0973%

$12.28M

+104.0%

Dier Mardi

EVP and CFO

—

$3.77M (28) scheduled

−$3.77M

12,490

0.0541%

$6.82M

+40.7%

Huntsman Carole

Chief Commercial Officer

—

$1.71M (14) scheduled

−$1.71M

12,692

0.0549%

$6.93M

+10.6%

Soergel David

Chief Medical Officer

—

$951.98K (2) scheduled

−$951.98K

10,033

0.0434%

$5.48M

—

Kelley Shannon T

General Counsel

—

$841.61K (4)

−$841.61K

11,474

0.0497%

$6.27M

+43.7%

BAKER BROS. ADVISORS LP entity

Director

—

1,948,876

8.44%

$1.06B

+9.6%

CRAVES FRED B

Director

—

361,076

1.56%

$197.28M

−1.9%

Waltermire Robert E.

Senior VP, Chief Pharma Dev.

—

5,789

0.0251%

$3.16M

+5.3%

Daly James M

Director

—

3,081

0.0133%

$1.68M

+61.1%

Thakkar Rita

Chief Accounting Officer

—

2,398

0.0104%

$1.31M

—

FOUSE JACQUALYN A

Director

—

1,551

0.0067%

$847.43K

—

Brennan Daniel J.

Director

—

1,371

0.0059%

$749.08K

—

REED JOHN C

Director

—

647

0.0028%

$353.51K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Kelley Shannon T

17 Aug 2026

General Counsel

Sell

664

$514.97

$341.94K

Sibold William John

20 Jul 2026

President and CEO

Sell

280

$555.05

$155.41K

Sibold William John

20 Jul 2026

President and CEO

Sell

$550.72

Sibold William John

20 Jul 2026

President and CEO

Sell

153

$550.01

$84.15K

Sibold William John

20 Jul 2026

President and CEO

Sell

$548.87

$25.80K

Sibold William John

20 Jul 2026

President and CEO

Sell

680

$547.70

$372.43K

Sibold William John

20 Jul 2026

President and CEO

Sell

269

$547.08

$147.16K

Sibold William John

20 Jul 2026

President and CEO

Sell

275

$545.71

$150.07K

Sibold William John

20 Jul 2026

President and CEO

Sell

545

$544.71

$296.87K

Sibold William John

20 Jul 2026

President and CEO

Sell

110

$543.79

$59.82K

Sibold William John

20 Jul 2026

President and CEO

Sell

140

$542.75

$75.98K

Soergel David

18 May 2026

Chief Medical Officer

Sell

844

$515.90

$435.42K

Taub Rebecca

6 Mar 2026

Director

Sell

491

$431.94

$212.08K

Huntsman Carole

6 Mar 2026

Chief Commercial Officer

Sell

419

$431.94

$180.98K

Kelley Shannon T

6 Mar 2026

General Counsel

Sell

360

$431.94

$155.50K

Sibold William John

6 Mar 2026

President and CEO

Sell

1,663

$431.94

$718.32K

Dier Mardi

2 Mar 2026

EVP and CFO

Sell

1,183

$427.21

$505.39K

Taub Rebecca

26 Jan 2026

Director

Sell

647

$492.42

$318.60K

Sibold William John

26 Jan 2026

President and CEO

Sell

1,577

$492.42

$776.55K

Taub Rebecca

20 Jan 2026

Director

Sell

2,238

$490.77

$1.10M

Sibold William John

4 Dec 2025

President and CEO

Sell

2,400

$575.34

$1.38M

Show all 204 transactions →

MADRIGAL PHARMACEUTICALS, INC.

By person

Individual transactions

What was left out